Jiangsu Jibeier Pharmaceutical (SH:688566) Xin Lang Cai Jing·2025-10-31 05:57Group 1 - The core point of the news is that Jibeier's stock price increased by 5.07% to 34.62 CNY per share, with a trading volume of 213 million CNY and a turnover rate of 3.22%, resulting in a total market capitalization of 6.904 billion CNY [1] - Jibeier Pharmaceutical Co., Ltd. is located in the High-tech Industrial Development Zone of Zhenjiang, Jiangsu Province, established on November 13, 2001, and listed on May 18, 2020. The company specializes in drug research, production, and sales [1] - The main revenue composition of Jibeier includes: Likujun tablets 72.72%, Niqunlol tablets 14.20%, Yupingfeng capsules 4.88%, others 4.53%, and Acetylsalicylic Acid Enteric-coated Tablets 3.67% [1] Group 2 - From the perspective of the top ten holdings of funds, data shows that one fund under Guotai Fund has a significant position in Jibeier. Guotai Ju Li Value Regular Open Flexible Allocation Mixed Fund (005746) held 70,000 shares in the third quarter, accounting for 1.18% of the fund's net value, ranking as the fifth-largest holding [2] - The Guotai Ju Li Value Regular Open Flexible Allocation Mixed Fund (005746) was established on March 27, 2018, with a latest scale of 212 million CNY. Year-to-date return is 5.51%, ranking 6703 out of 8235 in its category; the one-year return is 6.2%, ranking 6652 out of 8105; and since inception, the return is 47.03% [2] Group 3 - The fund managers of Guotai Ju Li Value Regular Open Flexible Allocation Mixed Fund (005746) are Cheng Zhou and Cheng Yao. As of the report, Cheng Zhou has a cumulative tenure of 17 years and 216 days, with a total fund asset size of 7.788 billion CNY, achieving the best fund return of 386.87% and the worst return of -37% during his tenure [3] - Cheng Yao has a cumulative tenure of 4 years and 116 days, with a total fund asset size of 1.503 billion CNY, achieving the best fund return of 15.83% and the worst return of 5.11% during her tenure [3]